Contemporary use of antiplatelet therapies in percutaneous coronary interventions

被引：2
|
作者：
Saw, J [1 ]
Moliterno, DJ [1 ]
机构：
[1] Cleveland Clin Fdn, Dept Cardiovasc Med, Cleveland, OH 44195 USA
来源：
CORONARY ARTERY DISEASE | 2003年 / 14卷 / 05期
关键词：
antiplatelet agents; stents; angioplasty; aspirin; thienopyridine; glycoprotein IIb/IIIa inhibitors; clopidogrel;
D O I：
10.1097/00019501-200308000-00004
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：373 / 380
页数：8
相关论文
共 50 条
  • [1] Novel antiplatelet therapies following percutaneous coronary interventions
    Ahrens, Ingo
    Bode, Christoph
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2009, 10 (09) : 902 - 911
  • [2] Antiplatelet Therapy and Percutaneous Coronary Interventions
    Davanzo, Rene Hameau
    Alarcon, Alberto Fuensalida
    Calquin, Jorge Quitral
    Varela, Pablo Sepulveda
    Sepulveda, Alejandro Martinez
    Herreros, Ramon Corbalan
    Patel, Sanjay
    Rodriguez, Gonzalo Martinez
    CURRENT CARDIOLOGY REVIEWS, 2021, 17 (03) : 302 - 313
  • [3] Percutaneous coronary interventions and antiplatelet therapy in the perioperative period
    Mauermann, William J.
    Rehfeldt, Kent H.
    Bell, Malcolm R.
    Lowson, Stuart M.
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2007, 21 (03) : 436 - 442
  • [4] The Role of Coronary Physiology in Contemporary Percutaneous Coronary Interventions
    Marin, Federico
    Scarsini, Roberto
    Terentes-Printzios, Dimitrios
    Kotronias, Rafail A.
    Ribichini, Flavio
    Banning, Adrian P.
    De Maria, Giovanni Luigi
    CURRENT CARDIOLOGY REVIEWS, 2022, 18 (01) : 44 - 62
  • [5] Improving outcomes with antiplatelet therapies in percutaneous coronary intervention and stenting
    Hobson, Alex
    Curzen, Nick
    THROMBOSIS AND HAEMOSTASIS, 2009, 101 (01) : 23 - 30
  • [6] Emerging Antiplatelet Therapies in Percutaneous Coronary Intervention: A Focus on Prasugrel
    Martin, Michelle T.
    Spinier, Sarah A.
    Nutescu, Edith A.
    CLINICAL THERAPEUTICS, 2011, 33 (04) : 425 - 442
  • [7] Contemporary antiplatelet therapy in patients undergoing percutaneous coronary intervention
    Bhatty, Shaun
    Ali, Asghar
    Shetty, Ranjith
    Sumption, Kevin F.
    Cowley, Michael J.
    Jovin, Ion S.
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2014, 12 (04) : 463 - 474
  • [8] Contemporary Trends in Oral Antiplatelet Agent Use in Patients Treated with Percutaneous Coronary Intervention for Acute Coronary Syndrome
    Kim, Kibum
    Lee, Todd A.
    Touchette, Daniel R.
    DiDomenico, Robert J.
    Ardati, Amer K.
    Walton, Surrey M.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2017, 23 (01): : 57 - 63
  • [9] CONTEMPORARY TRENDS AND PREDICTORS OF ANTIPLATELET AGENT USE IN PATIENTS WITH ACUTE CORONARY SYNDROME FOLLOWING PERCUTANEOUS CORONARY INTERVENTION
    Kim, Kibum
    Ardati, Amer
    Lee, Todd A.
    Touchette, Daniel
    DiDomenico, Robert
    Walton, Surrey M.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 538 - 538
  • [10] Antiplatelet medications in acute coronary syndromes and percutaneous coronary interventions: focus on tirofiban
    Batyraliev, T. A.
    Preobrazhensky, D., V
    Fetzer, D., V
    Sidorenko, B. A.
    Pataraya, S. A.
    CARDIOVASCULAR THERAPY AND PREVENTION, 2008, 7 (06): : 79 - 88
12345